Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Mr. Mark H. NawackiIndependent Director | 15,00k | 0,00 | Achat | - | 40,00k | 60,00% |
| 2026-04-06 | Mr. Mark H. NawackiIndependent Director | 10,00k | 0,00 | Achat | - | 25,00k | 66,67% |
| 2026-04-02 | Mr. Francis GleesonCo-Founder, CEO, President & Director | 108,63k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 624,94k | 21,04% |
| 2026-04-02 | Ms. Antoinette PaoneChief Development Officer & Head of Regulatory Affairs | 26,86k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 104,16k | 34,75% |
| 2026-04-02 | Dr. Philip LambertChief Scientific Officer | 36,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 234,13k | 18,30% |
| 2026-04-02 | Dr. Wildon FarwellChief Medical Officer | 54,31k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 208,31k | 35,27% |
| 2026-04-02 | Ms. Elizabeth WilliamsCFO & Corporate Secretary | 36,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 208,31k | 21,04% |
| 2026-04-02 | Dr. Michael A. RudnickiCo-Founder & Chief Discovery Officer | 36,66k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 260,39k | 16,39% |
| 2026-03-12 | Mr. Mark H. NawackiIndependent Director | 15,00k | 0,00 | Achat | - | 15,00k | - |
| 2026-01-30 | Mr. Francis GleesonCo-Founder, CEO, President & Director | -5,68M | 0,00 | Other Derivative Disposition | - | 516,31k | -91,67% |
| 2026-01-30 | Dr. Michael A. RudnickiCo-Founder & Chief Discovery Officer | -2,46M | 0,00 | Other Derivative Disposition | - | 223,73k | -91,67% |
| 2026-02-09 | Mr. Franklin M. BergerIndependent Director | 24,75k | 249,98k | Achat | 10,10 | 681,33k | 3,77% |
| 2026-01-30 | Mr. Franklin M. BergerIndependent Director | -205,12k | 0,00 | Other Derivative Disposition | - | 18,65k | -91,67% |
| 2026-01-30 | Mr. Geoff MacKayIndependent Chairman of the Board of Directors | -504,05k | 0,00 | Other Derivative Disposition | - | 45,82k | -91,67% |
| 2026-01-30 | Ms. Elizabeth WilliamsCFO & Corporate Secretary | -1,89M | 0,00 | Other Derivative Disposition | - | 172,10k | -91,67% |
| 2026-01-30 | Mr. Adam S. MostafaIndependent Director | -250,91k | 0,00 | Other Derivative Disposition | - | 22,81k | -91,67% |
| 2026-01-30 | Dr. Selwyn HoIndependent Director | -202,83k | 0,00 | Other Derivative Disposition | - | 18,44k | -91,67% |
| 2026-01-30 | Dr. Wildon FarwellChief Medical Officer | -1,69M | 0,00 | Other Derivative Disposition | - | 154,00k | -91,67% |
| 2026-01-30 | Dr. Philip LambertChief Scientific Officer | -2,18M | 0,00 | Other Derivative Disposition | - | 197,92k | -91,67% |
| 2026-01-30 | Ms. Stephanie BrownIndependent Director | -205,72k | 0,00 | Other Derivative Disposition | - | 18,70k | -91,67% |
| 2026-01-30 | Dr. Iris Low-FriedrichIndependent Director | -202,83k | 0,00 | Other Derivative Disposition | - | 18,44k | -91,67% |
| 2026-01-22 | Ms. Antoinette PaoneChief Development Officer & Head of Regulatory Affairs | 6,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 111,65 | 6,44k | - |
| 2025-11-14 | Mr. Mark H. NawackiIndependent Director | 18,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,91 | 18,44k | - |
| 2025-09-13 | Mr. Francis GleesonCo-Founder, CEO, President & Director | -10,42k | 0,00 | Other Derivative Disposition | 5,20 | 0,00 | -100,00% |
| 2025-09-13 | Mr. Brian Matthew BloomIndependent Director | -20,83k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-09-13 | Bloom Burton Investment Group Inc.Société | -42,29k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-08-15 | Dr. Wildon FarwellChief Medical Officer | 154,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,04 | 154,00k | - |
| 2025-06-18 | Dr. Selwyn HoIndependent Director | 18,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 18,44k | - |
| 2025-06-18 | Dr. Iris Low-FriedrichIndependent Director | 18,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 18,44k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
